Suppr超能文献

含GluN2A的N-甲基-D-天冬氨酸受体负变构调节的结构基础

Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.

作者信息

Yi Feng, Mou Tung-Chung, Dorsett Katherine N, Volkmann Robert A, Menniti Frank S, Sprang Stephen R, Hansen Kasper B

机构信息

Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT 59812, USA.

Center for Biomolecular Structure and Dynamics, University of Montana, Missoula, MT 59812, USA; Division of Biological Sciences, University of Montana, Missoula, MT 59812, USA.

出版信息

Neuron. 2016 Sep 21;91(6):1316-1329. doi: 10.1016/j.neuron.2016.08.014. Epub 2016 Sep 8.

Abstract

NMDA receptors mediate excitatory synaptic transmission and regulate synaptic plasticity in the central nervous system, but their dysregulation is also implicated in numerous brain disorders. Here, we describe GluN2A-selective negative allosteric modulators (NAMs) that inhibit NMDA receptors by stabilizing the apo state of the GluN1 ligand-binding domain (LBD), which is incapable of triggering channel gating. We describe structural determinants of NAM binding in crystal structures of the GluN1/2A LBD heterodimer, and analyses of NAM-bound LBD structures corresponding to active and inhibited receptor states reveal a molecular switch in the modulatory binding site that mediate the allosteric inhibition. NAM binding causes displacement of a valine in GluN2A and the resulting steric effects can be mitigated by the transition from glycine bound to apo state of the GluN1 LBD. This work provides mechanistic insight to allosteric NMDA receptor inhibition, thereby facilitating the development of novel classes NMDA receptor modulators as therapeutic agents.

摘要

NMDA受体介导中枢神经系统中的兴奋性突触传递并调节突触可塑性,但其功能失调也与多种脑部疾病有关。在此,我们描述了GluN2A选择性负变构调节剂(NAMs),它们通过稳定GluN1配体结合域(LBD)的无配体状态来抑制NMDA受体,该无配体状态无法触发通道门控。我们在GluN1/2A LBD异二聚体的晶体结构中描述了NAM结合的结构决定因素,并且对与活性和抑制性受体状态相对应的NAM结合LBD结构的分析揭示了介导变构抑制的调节性结合位点中的分子开关。NAM结合导致GluN2A中的缬氨酸位移,并且从与GluN1 LBD的无配体状态结合的甘氨酸转变可以减轻由此产生的空间效应。这项工作为变构性NMDA受体抑制提供了机制性见解,从而促进了新型NMDA受体调节剂作为治疗剂的开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d11/5033714/7fc1b31e061b/nihms-811104-f0001.jpg

相似文献

3
6
7
Negative allosteric modulation of GluN1/GluN3 NMDA receptors.谷氨酸 N-甲基-D-天冬氨酸受体 GluN1/GluN3 的负变构调节。
Neuropharmacology. 2020 Oct 1;176:108117. doi: 10.1016/j.neuropharm.2020.108117. Epub 2020 May 7.

引用本文的文献

3
Advances in the Structural Basis of GluN2A-Selective Negative Allosteric Modulators.GluN2A选择性负变构调节剂结构基础的研究进展
ACS Med Chem Lett. 2025 May 9;16(6):911-915. doi: 10.1021/acsmedchemlett.5c00226. eCollection 2025 Jun 12.
4
NMDA Receptors: Next therapeutic targets for Tinnitus?NMDA受体:耳鸣的下一个治疗靶点?
Biochem Biophys Rep. 2025 Apr 26;42:102029. doi: 10.1016/j.bbrep.2025.102029. eCollection 2025 Jun.

本文引用的文献

3
Pharmacology of triheteromeric N-Methyl-D-Aspartate Receptors.三聚体 N-甲基-D-天冬氨酸受体的药理学
Neurosci Lett. 2016 Mar 23;617:240-6. doi: 10.1016/j.neulet.2016.02.032. Epub 2016 Feb 23.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验